Atlas Trials

Study of Oral Vorinostat in Combination With Topotecan in Patients With Chemosensitive Recurrent SCLC

Clinical trial NCT00697476 · TERMINATED

Trial details

NCT number
NCT00697476
Sponsor
Armando Santoro, MD
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Cancer
Start date
2009-01-01
Primary completion
2009-09-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.